Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Drug Delivery: Parenteral Route

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

DNA damage-associated vesicle production in <i>Stenotrophomonas maltophilia</i> is mediated by the maltocin endolysin.

Journal of bacteriology·2026

Same author

Real-world evidence on In-hospital statin use and mortality in geriatric patients.

Acta clinica Belgica·2026

Same author

Navigating in the chemical space of peptides: computational strategies and molecular features to unveil their functional and drug-like properties.

Physical chemistry chemical physics : PCCP·2026

Same author

Cationic mRNA Lipid Nanoparticles for Ex Vivo NanoCAR-T Cell Engineering.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Patient-specific alterations in blood plasma cfRNA profiles enable accurate classification of cancer patients and controls.

Communications medicine·2026

Same author

Why we choose to publish on personalized medicine in dermatology.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Same journal

Dataset of pesticide and trace metal concentrations in the pollen provisions of wild bees and surrounding soils across European bee hotels.

Data in brief·2026

Same journal

Dataset of structure-activity relationships in Pd/ZrO<sub>2</sub>-TiO<sub>2</sub> catalysts for furfural reductive amination: Batch vs Operando ATR-FTIR.

Data in brief·2026

Same journal

Dine in or take out dataset: user behavior in an interactive virtual reality café.

Data in brief·2026

Same journal

Heavy commercial vehicles' disposition: Anonymized dataset of German truck freight transport order trips (DT-DISPO).

Data in brief·2026

Same journal

A harmonized fast-fashion garment-variant dataset for textile circularity and sustainability assessment.

Data in brief·2026

Same journal

Terahertz reflectivity dataset: Reading text on both sides of the page.

Data in brief·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 18, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Characterization data on the topical carrier DDC642.

Eline Desmet¹, Stefanie Bracke¹, Katrien Forier²

¹Department of Dermatology, Ghent University, Ghent, Belgium.

|July 14, 2016

Summary

This summary is machine-generated.

This study details the characterization of DDC642 elastic liposomes for topical RNA interference (RNAi) delivery. These liposomes show promise as superior carriers for treating skin disorders like psoriasis.

Keywords:

Gene therapy Lipid-based nanoparticle Liposome RNA interference Topical drug delivery

More Related Videos

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery

Published on: September 26, 2025

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

Related Experiment Videos

Last Updated: Mar 18, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery

Published on: September 26, 2025

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

Area of Science:

Dermatology
Nanotechnology
Molecular Biology

Background:

RNA interference (RNAi) offers potential for topical skin disorder treatment.
Elastic liposomes are being explored as carriers for RNAi delivery.
Previous liposome formulations (SECosomes) have been characterized.

Purpose of the Study:

To provide in-depth characterization of the DDC642 elastic liposomal carrier.
To detail methods for RNAi encapsulation and delivery using DDC642 liposomes.
To compare DDC642 liposomes with SECosomes for topical RNAi applications.

Main Methods:

Evaluation of elastic liposomal formulations for RNAi encapsulation.
Transfection efficiency assessment in cultured primary skin cells.
Detailed physicochemical characterization of DDC642 liposomes and lipoplexes.

Main Results:

DDC642 liposomes demonstrated superior encapsulation and transfection efficiency compared to SECosomes.
Comprehensive characterization data for DDC642 liposomes and RNAi-loaded lipoplexes are presented.
Protocols for DDC642 liposome preparation and characterization are included.

Conclusions:

DDC642 elastic liposomes represent a promising carrier for topical RNAi-based therapies.
The detailed characterization supports the potential of DDC642 for skin disorder treatment.
This work provides a foundation for further development of RNAi therapeutics.